title: Identification of ovarian cancer metastatic miRNAs.
abstract: Serous epithelial ovarian cancer (EOC) patients often succumb to aggressive metastatic disease, yet little is known about the behavior and genetics of ovarian cancer metastasis. Here, we aim to understand how omental metastases differ from primary tumors and how these differences may influence chemotherapy. We analyzed the miRNA expression profiles of primary EOC tumors and their respective omental metastases from 9 patients using miRNA Taqman qPCR arrays. We find 17 miRNAs with differential expression in omental lesions compared to primary tumors. miR-21, miR-150, and miR-146a have low expression in most primary tumors with significantly increased expression in omental lesions, with concomitant decreased expression of predicted mRNA targets based on mRNA expression. We find that miR-150 and miR-146a mediate spheroid size. Both miR-146a and miR-150 increase the number of residual surviving cells by 2-4 fold when challenged with lethal cisplatin concentrations. These observations suggest that at least two of the miRNAs, miR-146a and miR-150, up-regulated in omental lesions, stimulate survival and increase drug tolerance. Our observations suggest that cancer cells in omental tumors express key miRNAs differently than primary tumors, and that at least some of these microRNAs may be critical regulators of the emergence of drug resistant disease.
authors.affiliation: Department of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, Rhode Island, USA.
authors.forename: Souriya
authors.initials: S
authors.lastname: Vang
authors.forename: Hsin-Ta
authors.initials: HT
authors.lastname: Wu
authors.forename: Andrew
authors.initials: A
authors.lastname: Fischer
authors.forename: Daniel H
authors.initials: DH
authors.lastname: Miller
authors.forename: Shannon
authors.initials: S
authors.lastname: MacLaughlan
authors.forename: Elijah
authors.initials: E
authors.lastname: Douglass
authors.forename: Lauren
authors.initials: L
authors.lastname: Comisar
authors.forename: Margaret
authors.initials: M
authors.lastname: Steinhoff
authors.forename: Colin
authors.initials: C
authors.lastname: Collins
authors.forename: Peter J S
authors.initials: PJ
authors.lastname: Smith
authors.forename: Laurent
authors.initials: L
authors.lastname: Brard
authors.forename: Alexander S
authors.initials: AS
authors.lastname: Brodsky
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000494:pharmacology; D045744:Cell Line, Tumor; D002945:Cisplatin / Q000494:pharmacology; D019008:Drug Resistance, Neoplasm; D005260:Female; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D035683:MicroRNAs / Q000096:biosynthesis*; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010051:Ovarian Neoplasms / Q000378:metabolism* / Q000473:pathology; D012334:RNA, Neoplasm / Q000096:biosynthesis*; D018874:Spheroids, Cellular / Q000378:metabolism / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents; D035683:MicroRNAs; D012334:RNA, Neoplasm; D002945:Cisplatin
references.citation: Proc Natl Acad Sci U S A. 2007 Apr 24;104(17):7080-5
references.pmid: 17438277
references.citation: Nat Genet. 2003 Jan;33(1):49-54
references.pmid: 12469122
references.citation: EMBO Mol Med. 2011 May;3(5):279-90
references.pmid: 21472990
references.citation: Cancer Res. 2008 Apr 1;68(7):2329-39
references.pmid: 18381440
references.citation: Cancer Res. 2010 Nov 15;70(22):9234-42
references.pmid: 21045152
references.citation: Nucleic Acids Res. 2005 Nov 27;33(20):e179
references.pmid: 16314309
references.citation: Biochem Biophys Res Commun. 2010 Feb 12;392(3):340-5
references.pmid: 20067763
references.citation: Cell. 2007 Oct 5;131(1):146-59
references.pmid: 17923094
references.citation: Nat Rev Drug Discov. 2010 Oct;9(10):775-89
references.pmid: 20885409
references.citation: Head Neck. 2008 Oct;30(10):1273-83
references.pmid: 18642293
references.citation: Br J Cancer. 2004 Feb 9;90(3):686-92
references.pmid: 14760385
references.citation: Cell Cycle. 2008 May 15;7(10):1353-9
references.pmid: 18418074
references.citation: Int J Cancer. 2009 May 1;124(9):2060-70
references.pmid: 19132753
references.citation: Nat Genet. 2011 Aug 21;43(9):854-9
references.pmid: 21857679
references.citation: Oncol Rep. 2012 Jan;27(1):129-34
references.pmid: 21935578
references.citation: Semin Oncol. 2011 Dec;38(6):724-33
references.pmid: 22082758
references.citation: Cancer Res. 2008 Jun 15;68(12):4606-13
references.pmid: 18559505
references.citation: Cell. 2010 Apr 2;141(1):69-80
references.pmid: 20371346
references.citation: Cell Prolif. 2009 Apr;42(2):219-28
references.pmid: 19222485
references.citation: Nat Med. 2011 Oct 30;17(11):1498-503
references.pmid: 22037646
references.citation: Mol Carcinog. 2007 Oct;46(10):872-85
references.pmid: 17455221
references.citation: Am J Pathol. 2001 Dec;159(6):2071-80
references.pmid: 11733357
references.citation: PLoS One. 2012;7(3):e34546
references.pmid: 22479643
references.citation: Methods Mol Biol. 2012;822:67-84
references.pmid: 22144192
references.citation: Oncogene. 2008 Sep 18;27(42):5643-7
references.pmid: 18504431
references.citation: Breast Cancer Res Treat. 2010 Jul;122(1):35-43
references.pmid: 19701706
references.citation: Biotechniques. 2007 Oct;43(4):494, 496-500
references.pmid: 18019341
references.citation: Nat Genet. 2007 Oct;39(10):1278-84
references.pmid: 17893677
references.citation: Cancer Res. 2009 Sep 1;69(17):7121-9
references.pmid: 19706774
references.citation: J Biol Chem. 2008 Oct 17;283(42):28274-86
references.pmid: 18682393
references.citation: Neoplasia. 2006 Dec;8(12):1083-9
references.pmid: 17217626
references.citation: Leukemia. 2011 Aug;25(8):1324-34
references.pmid: 21502955
references.citation: Cell. 2003 Jun 27;113(7):821-3
references.pmid: 12837240
references.citation: Gynecol Oncol. 2009 Apr;113(1):143-8
references.pmid: 19135710
references.citation: Gut. 2012 Oct;61(10):1447-53
references.pmid: 22052060
references.citation: J Natl Cancer Inst. 2007 Oct 3;99(19):1441-54
references.pmid: 17895480
references.citation: Am J Physiol Heart Circ Physiol. 2010 Oct;299(4):H1077-82
references.pmid: 20656888
references.citation: Cell. 2005 Jan 14;120(1):15-20
references.pmid: 15652477
references.citation: Nature. 2009 Jun 18;459(7249):1005-9
references.pmid: 19421193
references.citation: Hum Mol Genet. 2004 Jul 1;13(13):1303-13
references.pmid: 15138198
references.citation: J Pathol. 2008 Mar;214(4):489-97
references.pmid: 18213732
references.citation: J Cell Mol Med. 2009 Jan;13(1):39-53
references.pmid: 19175699
references.citation: Cancer Res. 2010 Nov 15;70(22):9319-28
references.pmid: 21062986
references.citation: Am J Pathol. 2004 Aug;165(2):397-414
references.pmid: 15277215
references.citation: Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1733-45
references.pmid: 17009964
references.citation: Clin Exp Metastasis. 2008;25(6):643-55
references.pmid: 18398687
references.citation: Am J Pathol. 2010 Sep;177(3):1053-64
references.pmid: 20651229
references.citation: Nature. 2008 Sep 4;455(7209):64-71
references.pmid: 18668037
references.citation: Cancer Cell. 2012 Feb 14;21(2):227-39
references.pmid: 22340595
references.citation: Nature. 2009 Oct 8;461(7265):809-13
references.pmid: 19812674
references.citation: Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12481-6
references.pmid: 16885212
references.citation: Nature. 2010 Oct 28;467(7319):1114-7
references.pmid: 20981102